Generation Bio Competitors and Similar CompaniesClear all
Generation Bio's competitors and similar companies include Cimeio, XBiotech, Adverum Biotechnologies and SwanBio Therapeutics.
 Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. |  XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
|  Adverum Biotechnologies Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases. |  SwanBio Therapeutics SwanBio Therapeutics is a gene therapy company developing medicines for the treatment of neurological diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2020 | Founding Date 2005 | Founding Date 2006 | Founding Date 2018 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Basel, CH HQ | Locations Austin, US HQ | Locations Redwood City, US HQ Philadelphia, US | Locations Philadelphia, US HQ Cambridge, US |
Employees | Employees 85 | Employees 21 | Employees 8510% decrease | Employees 11419% increase | Employees 625% decrease |
Valuation ($) | Valuation ($) 159.5 m | Valuation ($) N/A | Valuation ($) 234.4 m | Valuation ($) 161.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $19.9m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1m (FY, 2024) | Revenue (est.) N/A |
Net income | Net income ($131.7m) (FY, 2024) | Net income N/A | Net income ($45.5m) (FY, 2025) | Net income ($130.9m) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 52m (about 6 years ago) |
Total funding raised | Total funding raised $ 235m | Total funding raised $ 50m | Total funding raised N/A | Total funding raised $ 70.7m | Total funding raised $ 52m |
For sources of this data, please see the company profile
View Company Profiles
Cimeio
HQ
Basel, CH
Employees
21
Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.
View companyXBiotech
HQ
Austin, US
Employees
85↓ 10% decrease
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
View companyAdverum Biotechnologies
HQ
Redwood City, US
Employees
114↑ 19% increase
Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
View companySwanBio Therapeutics
HQ
Philadelphia, US
Employees
6↓ 25% decrease
SwanBio Therapeutics is a gene therapy company developing medicines for the treatment of neurological diseases.
View company